[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (154)

Search Parameters:
Keywords = Franz-cell permeation

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
20 pages, 7172 KiB  
Article
Eutectogel-Based Drug Delivery: An Innovative Approach for Atenolol Administration
by Roberta Cassano, Roberta Sole, Carlo Siciliano, Noemi Baldino, Olga Mileti, Debora Procopio, Federica Curcio, Gabriella Calviello, Simona Serini, Sonia Trombino and Maria Luisa Di Gioia
Pharmaceutics 2024, 16(12), 1552; https://doi.org/10.3390/pharmaceutics16121552 - 4 Dec 2024
Viewed by 468
Abstract
Background: Hypertension affects 32% of adults worldwide, leading to a significant global consumption of cardiovascular medications. Atenolol, a β-adrenergic receptor blocker, is widely prescribed for cardiovascular diseases such as hypertension, angina pectoris, and myocardial infarction. According to the Biopharmaceutics Classification System (BCS), atenolol [...] Read more.
Background: Hypertension affects 32% of adults worldwide, leading to a significant global consumption of cardiovascular medications. Atenolol, a β-adrenergic receptor blocker, is widely prescribed for cardiovascular diseases such as hypertension, angina pectoris, and myocardial infarction. According to the Biopharmaceutics Classification System (BCS), atenolol belongs to Class III, characterized by high solubility but low permeability. Currently, atenolol is commercially available in oral formulations. Increasing attention is being directed towards developing cost-effective transdermal delivery systems, due to their ease of use and better patient compliance. Eutectogels represent next-generation systems that are attracting great interest in the scientific community. Typically obtained from deep eutectic solvents (DESs) combined with gelling agents, these systems exhibit unique properties due to the intrinsic characteristics of DESs. Methods: In this study, a DES based on choline chloride as a hydrogen bond acceptor (HBA) and propylene glycol as a hydrogen bond donor (HBD) was explored to enhance the topical delivery of atenolol. The solubility of atenolol in the DES was evaluated using spectroscopic and thermodynamic measurements which confirmed the formation of hydrogen bonds between the drug and DES components. Additionally, the safety of the DES was assessed in a cell viability assay. Subsequently, we formulated eutectogels with different concentrations using animal gelatin and Tego Carbomer 140, and characterized these formulations through rheological measurements, swelling percentage, and permeation studies with Franz cells. Results: These novel eutectogels exhibit superior performance over conventional hydrogels, with a release rate of approximately 86% and 51% for Carbomer- and gelatin-based eutectogels, respectively. In contrast, comparable hydrogels released only about 27% and 35%. Conclusions: These findings underscore the promising potential of eutectogels for the transdermal delivery of atenolol. Full article
(This article belongs to the Topic Challenges and Opportunities in Drug Delivery Research)
Show Figures

Figure 1

Figure 1
<p>Eutectogels prepared in this study.</p>
Full article ">Figure 2
<p>DSC thermograms of atenolol (ATL), ChCl:PG DES, and drug–DES mixture.</p>
Full article ">Figure 3
<p>FT-IR analysis of (ChCl:PG) DES, atenolol (ATL), and (ChCl:PG) DES with atenolol.</p>
Full article ">Figure 4
<p><sup>1</sup>H NMR spectra of atenolol (<b>A</b>) and DES (<b>B</b>).</p>
Full article ">Figure 4 Cont.
<p><sup>1</sup>H NMR spectra of atenolol (<b>A</b>) and DES (<b>B</b>).</p>
Full article ">Figure 5
<p>Homonuclear two-dimensional spectrum of the ChCl:PG DES.</p>
Full article ">Figure 6
<p><sup>1</sup>H NMR spectra of (ClCh:PG)DES-ATL (<b>A</b>) and <sup>13</sup>C NMR spectra of (ClCh:PG)DES-ATL (<b>B</b>).</p>
Full article ">Figure 6 Cont.
<p><sup>1</sup>H NMR spectra of (ClCh:PG)DES-ATL (<b>A</b>) and <sup>13</sup>C NMR spectra of (ClCh:PG)DES-ATL (<b>B</b>).</p>
Full article ">Figure 7
<p>The effect of increasing concentrations (0.5–5 µg/mL) of DES on the viability of human THP-1 monocytes and immortalized human NCTC 2544 keratinocytes treated for various periods (24–72 h). Values not sharing the same lowercase letter are significantly different (<span class="html-italic">p</span> &lt; 0.05, one-way ANOVA followed by Tukey’s test).</p>
Full article ">Figure 8
<p>The new eutectogels prepared: (<b>A</b>) gelatin-based eutectogel; (<b>B</b>) carbomer-based eutectogel.</p>
Full article ">Figure 9
<p>Time cure of gelatin–water-based gels (<b>a</b>,<b>c</b>) and gelatin–DES-based gels (<b>b</b>,<b>d</b>) in terms of complex modulus G* (<b>a</b>,<b>b</b>) and phase angle δ (<b>c</b>,<b>d</b>).</p>
Full article ">Figure 10
<p>Time cure of carbomer–water-based gels (<b>a</b>,<b>c</b>) and carbomer–DES-based gels (<b>b</b>,<b>d</b>) in terms of complex modulus G* (<b>a</b>,<b>b</b>) and phase angle (<b>c</b>,<b>d</b>).</p>
Full article ">Figure 11
<p>Comparison of A parameter for carbomer and gelatin in water and DES.</p>
Full article ">Figure 12
<p>Swelling of eutectogels and hydrogels with gelatin (<b>A</b>) and carbomer (<b>B</b>).</p>
Full article ">Figure 12 Cont.
<p>Swelling of eutectogels and hydrogels with gelatin (<b>A</b>) and carbomer (<b>B</b>).</p>
Full article ">Figure 13
<p>(<b>A</b>) Drug permeation by gels based on Carbomer 140–DES and Carbomer 140–water. (<b>B</b>) Drug release by gels based on gelatin–DES and gelatin–water.</p>
Full article ">Figure 13 Cont.
<p>(<b>A</b>) Drug permeation by gels based on Carbomer 140–DES and Carbomer 140–water. (<b>B</b>) Drug release by gels based on gelatin–DES and gelatin–water.</p>
Full article ">
19 pages, 4721 KiB  
Article
Antiaging Properties of Kalanchoe blossfeldiana Ethanol Extract—Ex Vivo and In Vitro Studies
by Justyna Stefanowicz-Hajduk, Anna Nowak, Anna Hering, Łukasz Kucharski, Piotr Graczyk, Mariusz Kowalczyk, Tadeusz Sulikowski and Anna Muzykiewicz-Szymańska
Molecules 2024, 29(23), 5548; https://doi.org/10.3390/molecules29235548 - 24 Nov 2024
Viewed by 621
Abstract
Species of the genus Kalanchoe have a long history of therapeutic use in ethnomedicine, linked to their remarkable medical properties. These species include Kalanchoe blossfeldiana succulents, which grow in tropical regions. Despite the great interest in this plant, there are no reports about [...] Read more.
Species of the genus Kalanchoe have a long history of therapeutic use in ethnomedicine, linked to their remarkable medical properties. These species include Kalanchoe blossfeldiana succulents, which grow in tropical regions. Despite the great interest in this plant, there are no reports about its therapeutic effects on the skin. In this study, the antioxidant properties of K. blossfeldiana ethanol extracts and the skin permeation of a topical hydrogel containing the extract (HKB) were assessed. Additionally, the content of active compounds in the K. blossfeldiana extract was evaluated by UHPLC-MS and HPLC-UV. The extract was analyzed with three antioxidant assays: ABTS, DPPH, and FRAP. Furthermore, the antielastase and antihialuronidase properties of the tested extract were assessed. Ex vivo penetration studies were performed using the Franz diffusion cells. The estimation of the cytotoxicity of HKB was performed by using an MTT assay ((4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) on the human fibroblasts HFF-1. The results obtained show that the antioxidant properties of K. blossfeldiana extract were similar to those of ascorbic acid, while antielastase and antihialuronidase tests indicated the strong antiaging and anti-inflammatory activity of the extract (IC50 was 26.8 ± 0.13 and 77.31 ± 2.44 µg/mL, respectively). Moreover, active ingredients contained in K. blossfeldiana extract penetrated through the human skin and accumulated in it. The cytotoxicity test showed that HKB had no significant effect on human fibroblasts at a concentration up to 0.5%. In conclusion, the hydrogel containing the K. blossfeldiana extract can be considered as an interesting and new alternative to dermatologic and cosmetic preparations. Full article
Show Figures

Figure 1

Figure 1
<p>Chromatogram of phenolic acid identified in <span class="html-italic">K. blossfeldiana</span> ethanol extract from leaves. A—gallic acid; B—protocatechuic acid; C—gentistic acid; D—<span class="html-italic">m</span>-hydroxybenzoic acid; E—vanilic acid; F—hypogallic acid; G—<span class="html-italic">p</span>-hydroxybenzoic acid. The samples were diluted tenfold before HPLC analysis.</p>
Full article ">Figure 2
<p>Hyaluronidase activity in the presence of a <span class="html-italic">K. blossfeldiana</span> ethanol extract. The experiment was performed in three independent repetitions (<span class="html-italic">n</span> = 9). Error bars represent standard deviations.</p>
Full article ">Figure 3
<p>Elastase activity in the presence of a <span class="html-italic">K. blossfeldiana</span> ethanol extract. The experiment was performed in three independent repetitions (<span class="html-italic">n</span> = 9). Error bars represent standard deviations.</p>
Full article ">Figure 4
<p>The accumulation of phenolic acids in the skin. The content of individual phenolic acids was determined in the skin extraction fluid collected after the 24 h penetration study. All values are presented as mean ± SD, where n = 3; n.d.—not detected.</p>
Full article ">Figure 5
<p>The viability of HFF-1 cells treated with HKB at concentrations of 5% (<b>A</b>), 1% (<b>B</b>), and 0.5% (<b>C</b>) for 24 h. The results were obtained via an MTT assay and they are presented as the mean values of two experiments performed in three repetitions. Error bars indicate the standard deviation (±SD). Asterisks indicate significant differences (Student’s <span class="html-italic">t</span>-test, <span class="html-italic">p</span> &lt; 0.05) in comparison to the control (the cells treated with hydrogel without the extract).</p>
Full article ">Figure 6
<p>The microscopic observation of the viability of HFF-1 cells treated with HKB at concentrations of 5%, 1%, and 0.5% for 24 h. (<b>A</b>–<b>C</b>)—the control treated with hydrogel without the extract; (<b>D</b>,<b>G</b>,<b>J</b>)—cells treated with the extract amounts of 32, 640, and 1600 µg/cm<sup>2</sup> of 5% HKB; (<b>E</b>,<b>H</b>,<b>K</b>)—cells treated with the extract amounts of 32, 320, and 640 µg/cm<sup>2</sup> of 1% HKB; (<b>F</b>,<b>I</b>,<b>L</b>)—cells treated with extract amounts of 16, 64, and 320 µg/cm<sup>2</sup> of 0.5% HKB; magnification ×100.</p>
Full article ">
17 pages, 6852 KiB  
Article
Chitosan Nanoparticles Embedded in In Situ Gel for Nasal Delivery of Imipramine Hydrochloride: Short-Term Stage Development and Controlled Release Evaluation
by Samer Adwan, Teiba Obeidi and Faisal Al-Akayleh
Polymers 2024, 16(21), 3062; https://doi.org/10.3390/polym16213062 - 30 Oct 2024
Viewed by 961
Abstract
Imipramine hydrochloride (IMP), a tricyclic antidepressant used for major depression, enuresis, and neuropathic pain, is limited by gastrointestinal complications, low oral bioavailability (44%), and complex dosing requirements. This study aimed to explore a novel non-invasive nasal delivery system using chitosan nanoparticles (Cs NPs) [...] Read more.
Imipramine hydrochloride (IMP), a tricyclic antidepressant used for major depression, enuresis, and neuropathic pain, is limited by gastrointestinal complications, low oral bioavailability (44%), and complex dosing requirements. This study aimed to explore a novel non-invasive nasal delivery system using chitosan nanoparticles (Cs NPs) embedded in an in situ gel to address the limitations of oral IMP administration. Cs NPs loaded with IMP were synthesized via ionic gelation and assessed for precision in drug concentration using a validated HPLC method. The particles were integrated into a thermoresponsive polymer, Pluronic F127, to form an in situ gel suitable for nasal administration. The formulation was characterized for gelation temperature, duration, viscosity, mucoadhesive strength, and overall gel robustness. Drug release kinetics and the controlled release mechanism were studied using ex vivo permeation tests with Franz diffusion cells and nasal sheep mucosa. The optimized nanoparticle formulation (F4-50) exhibited a consistent PS of 141.7 ± 2.2 nm, a zeta potential (ZP) of 16.79 ± 2.1 mV, and a high encapsulation efficiency of 67.71 ± 1.9%. The selected in situ gel formulation, F4-50-P1, demonstrated a gelation temperature of 33.6 ± 0.94 °C and a rapid gelation time of 48.1 ± 0.7 s. Transform-attenuated total reflectance infrared spectroscopy (ATR-IR) confirmed the compatibility and effective encapsulation of IMP within the formulation. The release profile of F4-50 included an initial burst release followed by a sustained release phase, with F4-50-P1 showing improved control over the burst release. The flux rates were 0.50 ± 0.01 mg/cm2/h for F4-50 and 0.33 ± 0.06 mg/cm2/h for F4-50-P1, indicating effective permeation. The developed chitosan nanoparticle-based in situ gel formulation provides a promising approach for the controlled release of IMP, enhancing therapeutic efficacy and patient compliance while mitigating the disadvantages associated with oral delivery. Full article
(This article belongs to the Collection Polymers for Controlled Drug Release)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>TEM images of Formulation F4.</p>
Full article ">Figure 2
<p>FTIR fingerprint of individual components: IMP (<b>A</b>), STPP (<b>B</b>), and (<b>C</b>) Cs.</p>
Full article ">Figure 3
<p>FTIR fingerprint of physical blends: Cs and STPP (<b>A</b>), Cs and IMP (<b>B</b>), and IMP and STPP (<b>C</b>).</p>
Full article ">Figure 4
<p>FTIR of IMP (<b>A</b>), Cs NPs (<b>B</b>), and IMP-Cs NPs (<b>C</b>).</p>
Full article ">Figure 5
<p>FTIR of PF-127 (<b>A</b>) and IMP-Cs NPs ISG (<b>B</b>).</p>
Full article ">Figure 6
<p>The in vitro drug release results. Plotted in terms of % released of IMP in SNF vs. time for IMP-Cs NPs (F4-50) and IMP-solution (Mean ± SD, <span class="html-italic">n</span> = 3).</p>
Full article ">Figure 7
<p>The in vitro drug release results. Plotted in terms of % released of IMP in SNF vs. time for IMP-Cs NPs ISG (F4-50-P1) and IMP/ISG solution (Mean ± SD, <span class="html-italic">n</span> = 3).</p>
Full article ">Figure 8
<p>Ex vivo permeation study results of F4-50 and F4-50-P1 through nasal mucosa tissue using Franz cell (Mean ± SD, <span class="html-italic">n</span> = 3).</p>
Full article ">
20 pages, 3892 KiB  
Article
Exploring the Antifungal Effectiveness of a Topical Innovative Formulation Containing Voriconazole Combined with Pinus sylvestris L. Essential Oil for Onychomycosis
by Safaa Halool Mohammed Al-Suwaytee, Olfa Ben Hadj Ayed, Raja Chaâbane-Banaoues, Tahsine Kosksi, Maytham Razaq Shleghm, Leila Chekir-Ghedira, Hamouda Babba, Souad Sfar and Mohamed Ali Lassoued
Colloids Interfaces 2024, 8(5), 56; https://doi.org/10.3390/colloids8050056 - 17 Oct 2024
Viewed by 995
Abstract
(1) Background: The present study aimed to assess the antifungal effectiveness of a topical innovative formulation containing the association of an antifungal agent, voriconazole (VCZ), and the essential oil of Pinus sylvestris L. (PSEO). (2) Methods: Pseudo-ternary phase diagram and D-optimal mixture design [...] Read more.
(1) Background: The present study aimed to assess the antifungal effectiveness of a topical innovative formulation containing the association of an antifungal agent, voriconazole (VCZ), and the essential oil of Pinus sylvestris L. (PSEO). (2) Methods: Pseudo-ternary phase diagram and D-optimal mixture design approaches were applied for the development and the optimization of the o/w nanoemulsion. The optimized formulation (NE) was subjected to physicochemical characterization and to physical stability studies. In vitro permeation studies were carried out using the Franz cell diffusion system. The antimycotic efficacy against Microsporum canis was carried out in vitro. (3) Results: Optimal nanoemulsion showed great physical stability and was characterized by a small droplet size (19.015 nm ± 0.110 nm), a PDI of 0.146 ± 0.011, a zeta potential of −16.067 mV ± 1.833 mV, a percentage of transmittance of 95.352% ± 0.175%, and a pH of 5.64 ± 0.03. Furthermore, it exhibited a significant enhancement in apparent permeability coefficient (p < 0.05) compared to the VCZ free drug. Finally, NE presented the greatest antifungal activity against Microsporum canis in comparison with VCZ and PSEO tested alone. (4) Conclusions: These promising results suggest that this topical innovative formulation could be a good candidate to treat onychomycosis. Further ex vivo and clinical investigations are needed to support these findings. Full article
Show Figures

Figure 1

Figure 1
<p>Pseudo-ternary phase diagrams showing the nanoemulsion area composed of corn oil/PSES (1:1; <span class="html-italic">wt</span>/<span class="html-italic">wt</span>) as an oil mixture, Kolliphore<sup>®</sup> EL (surfactant)/Span<sup>®</sup> 80 (cosurfactant) (5:1; <span class="html-italic">wt</span>/<span class="html-italic">wt</span>) as Smix, Transcutol<sup>®</sup> HP as a cosolvent (CoS), and distilled water as a dispersant. Smix/CoS are tested at three different weight ratios: (<b>a</b>) (1:1; <span class="html-italic">wt</span>/<span class="html-italic">wt</span>), (<b>b</b>) (3:1; <span class="html-italic">wt</span>/<span class="html-italic">wt</span>), and (<b>c</b>) (5:1; <span class="html-italic">wt</span>/<span class="html-italic">wt</span>).</p>
Full article ">Figure 2
<p>Cox response trace plot of (<b>a</b>) droplet size (Y1) and (<b>b</b>) PDI (Y2) responses.</p>
Full article ">Figure 3
<p>Cell viability results of HacaT cells after incubation with different samples: voriconazole (VCZ), VCZ-loaded nanoemulsion (NE-VCZ), and unloaded nanoemulsion (NE-Blank). Data are expressed as mean ± SD (<span class="html-italic">n</span> = 4). Significant statistical differences: ** <span class="html-italic">p</span> &lt; 0.01 and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 4
<p>In vitro diffusion profiles of voriconazole free drug (<span class="html-fig-inline" id="colloids-08-00056-i001"><img alt="Colloids 08 00056 i001" src="/colloids/colloids-08-00056/article_deploy/html/images/colloids-08-00056-i001.png"/></span>) and optimized nanoemulsion (<span class="html-fig-inline" id="colloids-08-00056-i002"><img alt="Colloids 08 00056 i002" src="/colloids/colloids-08-00056/article_deploy/html/images/colloids-08-00056-i002.png"/></span>) using dialysis membrane as a model.</p>
Full article ">Figure 5
<p>Apparent permeability coefficient (Papp) across the dialysis membrane for VCZ pure drug and VCZ optimal nanoemulsion. Data are presented as mean ± standard error of three determinations (<span class="html-italic">n</span> = 3). * Significant at the level of 95% (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>Disk agar diffusion assay of voriconazole, <span class="html-italic">Pinus sylvestris</span> L. essential oil, blank nanoemulsion (unloaded), and VCZ-loaded nanoemulsion against <span class="html-italic">Microsporum canis</span> clinical strain.</p>
Full article ">
18 pages, 1778 KiB  
Article
In Vitro Study of Cyano-Phycocyanin Release from Hydrogels and Ex Vivo Study of Skin Penetration
by Daiva Galinytė, Jurga Bernatoniene, Modestas Žilius, Kristina Rysevaitė-Kyguolienė, Arūnas Savickas, Jūratė Karosienė, Vitalis Briedis, Dainius Haroldas Pauža and Nijolė Savickienė
Pharmaceuticals 2024, 17(9), 1224; https://doi.org/10.3390/ph17091224 - 17 Sep 2024
Viewed by 1129
Abstract
Background: This study explored the most suitable materials for incorporating cyano-phycocyanin (C-PC) into hydrogels, focusing on maintaining the C-PC’s long-term structural integrity and stabilityNext, the release of C-PC from the hydrogels and its skin penetration were investigated. Methods: A series of 1% ( [...] Read more.
Background: This study explored the most suitable materials for incorporating cyano-phycocyanin (C-PC) into hydrogels, focusing on maintaining the C-PC’s long-term structural integrity and stabilityNext, the release of C-PC from the hydrogels and its skin penetration were investigated. Methods: A series of 1% (w/w) C-PC hydrogels was prepared using various gelling agents and preservatives. Spectrophotometric measurements compared the amount of C-PC in the hydrogels to the initially added amount. After selecting the most suitable gelling agent and preservative, two C-PC hydrogels, with and without propylene glycol (PG) (Sigma-Aldrich, St. Louis, MO, USA), were produced for further testing. In vitro release studies utilized modified Franz-type diffusion cells, while ex vivo skin-permeation studies employed Bronaugh-type cells and human skin. Confocal laser scanning microscopy analyzed C-PC accumulation in the skin. Results: The findings demonstrated that sodium alginate (Sigma-Aldrich, St. Louis, MO, USA), hydroxyethyl cellulose (HEC) (Sigma-Aldrich, St. Louis, MO, USA), and SoligelTM (Givaudan, Vernier, Switzerland) are effective biopolymers for formulating hydrogels while maintaining C-PC stability. After 6 h, C-PC release from the hydrogel containing PG was approximately 10% or 728.07 (±19.35) μg/cm2, significantly higher than the nearly 7% or 531.44 (±26.81) μg/cm2 release from the hydrogel without PG (p < 0.05). The ex vivo qualitative skin-permeation study indicated that PG enhances C-PC penetration into the outermost skin layer. Conclusion: PG’s ability to enhance the release of C-PC from the hydrogel, coupled with its capacity to modify the skin barrier ex vivo, facilitates the penetration of C-PC into the stratum corneum. Full article
(This article belongs to the Special Issue Pharmaceutical Formulation Characterization Design)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>pH of hydrogels and determined concentrations of C-PC in the produced hydrogels with different gelling agents. An asterisk (*) indicates statistically significant differences between the added and determined concentrations of C-PC (<span class="html-italic">p</span> &lt; 0.05), evaluated using a paired-sample <span class="html-italic">t</span>-test. The means and standard deviations are presented. The experiment was repeated three times.</p>
Full article ">Figure 2
<p>Determined concentrations of C-PCs in hydrogels with different preservatives. Different letters denote statistically significant differences (<span class="html-italic">p</span> &lt; 0.05) in the C-PC concentrations among hydrogels containing the same gelling agent but different preservatives, as assessed using Bonferroni’s test. An asterisk (*) indicates statistically significant differences (<span class="html-italic">p</span> &lt; 0.05) between the initially added and the determined C-PC concentrations, evaluated using a paired-sample <span class="html-italic">t</span>-test. The means and standard deviations are presented. The experiment was repeated three times.</p>
Full article ">Figure 3
<p>The release of C-PC from hydrogels: C-PC PG hydrogel and C-PC hydrogel without PG (control). Different letters indicate statistically significant differences (<span class="html-italic">p</span> &lt; 0.05) determined by independent-samples <span class="html-italic">t</span>-test. Means and standard deviations are presented. The experiment was repeated 3 times.</p>
Full article ">Figure 4
<p>Confocal images of human skin autofluorescence (control) and human skin section after treatment with C-PC hydrogel and C-PC PG hydrogel. Scale bar 50 μm. The experiment was repeated 3 times.</p>
Full article ">
19 pages, 4388 KiB  
Article
Microspheres Based on Blends of Chitosan Derivatives with Carrageenan as Vitamin Carriers in Cosmeceuticals
by Kamila Lewicka, Anna Smola-Dmochowska, Piotr Dobrzyński, Natalia Śmigiel-Gac, Katarzyna Jelonek, Monika Musiał-Kulik and Piotr Rychter
Polymers 2024, 16(13), 1815; https://doi.org/10.3390/polym16131815 - 26 Jun 2024
Cited by 1 | Viewed by 1881
Abstract
Chitosan (CS) has a natural origin and is a biodegradable and biocompatible polymer with many skin-beneficial properties successfully used in the cosmetics and pharmaceutical industry. CS derivatives, especially those synthesized via a Schiff base reaction, are very important due to their unique antimicrobial [...] Read more.
Chitosan (CS) has a natural origin and is a biodegradable and biocompatible polymer with many skin-beneficial properties successfully used in the cosmetics and pharmaceutical industry. CS derivatives, especially those synthesized via a Schiff base reaction, are very important due to their unique antimicrobial activity. This study demonstrates research results on the use of hydrogel microspheres made of [chitosan-graft-poly(ε-caprolactone)]-blend-(ĸ-carrageenan)], [chitosan-2-pyridinecarboxaldehyde-graft-poly(ε-caprolactone)]-blend-(ĸ-carrageenan), and chitosan-sodium-4-formylbenzene-1,3-disulfonate-graft-poly(ε-caprolactone)]-blend-(ĸ-carrageenan) as innovative vitamin carriers for cosmetic formulation. A permeation study of retinol (vitamin A), L-ascorbic acid (vitamin C), and α-tocopherol (vitamin E) from the cream through a human skin model by the Franz Cell measurement system was presented. The quantitative analysis of the release of the vitamins added to the cream base, through the membrane, imitating human skin, showed a promising profile of its release/penetration, which is promising for the development of a cream with anti-aging properties. Additionally, the antibacterial activity of the polymers from which the microspheres are made allows for the elimination of preservatives and parabens as cosmetic formulation ingredients. Full article
Show Figures

Figure 1

Figure 1
<p>Scanning electron microscopy (SEM) images of microspheres CS-g-PCL(MSA):CG 50:50 loaded with VA vitamins (<b>a</b>) after receiving and (<b>b</b>) swelling microspheres after 12 h of incubation in apH 5.0 buffer.</p>
Full article ">Figure 2
<p>Scanning electron microscopy (SEM) images of microspheres CS-SB-PCA-g-PCL:CG 50:50 loaded with VA vitamins (<b>a</b>) after receiving and (<b>b</b>) swelling microspheres after 12 h of incubation in apH 5.0 buffer.</p>
Full article ">Figure 3
<p>Scanning electron microscopy (SEM) images of microspheres CS-SB-SFD-g-PCL:CG 50:50 loaded with VA vitamins (<b>a</b>) after receiving and (<b>b</b>) swelling microspheres after 12 h of incubation in a pH 5.0 buffer.</p>
Full article ">Figure 4
<p>The diameter distribution of the microspheres loaded with vitamins after receiving (before swelling) and after 12 h of incubation in a pH 5.0 buffer.</p>
Full article ">Figure 5
<p>Swelling ratio (SR) of microspheres at different soaking times in a pH 5.0 buffer at 34 °C. Error bars represent the standard deviation of three replicates.</p>
Full article ">Figure 6
<p>The relative mass loss (M<sub>s</sub>%) of microspheres after the incubation process in a pH 5.0 buffer at 34 °C. Error bars represent the standard deviation of three replicates.</p>
Full article ">Figure 7
<p>VA permeated through the Strat-MTM membrane: (<b>a</b>) 1 h doses and (<b>b</b>) cumulative release. Error bars represent the standard deviation of three replicates.</p>
Full article ">Figure 8
<p>VC permeated through the Strat-MTM membrane: (<b>a</b>) 1 h doses and (<b>b</b>) cumulative release. Error bars represent the the standard deviation of three replicates.</p>
Full article ">Figure 9
<p>VE permeated through the Strat-MTM membrane: (<b>a</b>) 1 h doses and (<b>b</b>) cumulative release. Error bars represent the standard deviation of three replicates.</p>
Full article ">Figure 10
<p>Relative vitamin content in the cream, membrane, and permeate after 6 h of the release process of VA (<b>a</b>), VC (<b>b</b>) and VE (<b>c</b>).</p>
Full article ">Figure 11
<p>The effect of the developed blends on the viability of human fibroblasts (the results are shown as the mean ± SD; * <span class="html-italic">p</span> &lt; 0.05 compared with the control).</p>
Full article ">Figure 12
<p>The effect of the developed blends on the viability of human keratinocytes (the results are shown as the mean ± SD; * <span class="html-italic">p</span> &lt; 0.05 compared with the control).</p>
Full article ">
16 pages, 1855 KiB  
Article
Electrospray-Mangiferin Nanoparticles Gel: A Promising Agent for Sun and Age Defense
by Neungreuthai Chomchoei, Pimporn Leelapornpisid, Pratchaya Tipduangta, Jakkapan Sirithunyalug, Busaban Sirithunyalug and Pawitrabhorn Samutrtai
Cosmetics 2024, 11(3), 93; https://doi.org/10.3390/cosmetics11030093 - 5 Jun 2024
Viewed by 1835
Abstract
UV irradiation causes skin damage and aging. This study aimed to develop and evaluate a gel formulation loaded with electrospray mangiferin nanoparticles (MNPs) as a double-action product with photoprotective and anti-aging properties. The MNPs were prepared using the electrospraying technique and loaded in [...] Read more.
UV irradiation causes skin damage and aging. This study aimed to develop and evaluate a gel formulation loaded with electrospray mangiferin nanoparticles (MNPs) as a double-action product with photoprotective and anti-aging properties. The MNPs were prepared using the electrospraying technique and loaded in a gel formulation. The MNP formulation was evaluated regarding its physical appearance, viscosity, in vitro sun protection factor (SPF), and in vitro anti-oxidant activity and compared with a formulation containing purified mangiferin (PM) at the same concentration of 0.2% (w/v). Moreover, both formulations were analyzed for their in vitro release and ex vivo skin permeation. The MNP formulation had a considerably higher SPF value than the PM formulation at the same concentration (20.43 ± 0.13 and 12.19 ± 0.27, respectively). The in vitro anti-oxidant activities of the formulations with MNPs and PM were 74.47 ± 2.19% and 80.52 ± 1.05%, respectively. The MNP formulation showed potent photoprotective and anti-oxidation activities with acceptable stability in all parameters under accelerated conditions (4 ± 2 °C 48 h/45 ± 2 °C 48 h for 6 cycles) and after 30 days of storage under various conditions. The release profile data of the MNPs showed a controlled release pattern at 76.97 ± 0.06% at 480 min. Furthermore, after using a Franz diffusion cell for 8 h, the MNP formulation showed the release of 37.01 ± 2.61% and 22.39 ± 1.59% of mangiferin content in the skin layer as stratum corneum and viable epidermis, respectively. Therefore, the overall results demonstrate that electrospray MNPs in a gel formulation are suitable for skin and constitute a promising delivery system for mangiferin in developing cosmetics and cosmeceutical products with good potential. Full article
Show Figures

Figure 1

Figure 1
<p>UV-VIS spectrum of (<b>a</b>) purified mangiferin and (<b>b</b>) mangiferin standard.</p>
Full article ">Figure 2
<p>Physical appearance of formulations F1 (loaded 0.2% PM) and F2 (loaded 0.2% MNPs) before (day 0) and after stability test; accelerated and 30-day storage under various conditions (day 30). RT = room temperature.</p>
Full article ">Figure 3
<p>Stability study of formulations F1 (loaded 0.2% PM) and F2 (loaded 0.2% MNPs) for in vitro anti-oxidant activity (<b>a</b>), and in vitro SPF (<b>b</b>) parameters compared with day 0. All data are presented as mean ± SD based on three measurements (<span class="html-italic">n</span> = 3). * denotes results that significantly differ from day 0 according to <span class="html-italic">t</span>-test statistics (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>Mangiferin release profile of formulations F1 (loaded 0.2% PM) and F2 (loaded 0.2% MNPs) in PBS pH 7.4. All data are presented as mean ± SD based on three measurements (<span class="html-italic">n</span> = 3). * denotes results that significantly differ from day 0 according to <span class="html-italic">t</span>-test statistics (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>The mangiferin content in the skin layers from using formulations F1 (loaded 0.2% PM) and F2 (loaded 0.2% MNPs): the percentage of stratum corneum, viable epidermis, and dermis. The quantitative content of mangiferin in all of the skin layers was determined using HPLC after 8 h. All data are presented as the mean ± SD based on three measurements (<span class="html-italic">n</span> = 3). * denotes the results that significantly differ from day 0 according to the <span class="html-italic">t</span>-test statistics (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
22 pages, 5833 KiB  
Article
A Novel Approach for Dermal Application of Pranoprofen-Loaded Lipid Nanoparticles for the Treatment of Post-Tattoo Inflammatory Reactions
by Guillermo De Grau-Bassal, Mireia Mallandrich, Lilian Sosa, Lupe Espinoza, Ana Cristina Calpena, Núria Bozal-de Febrer, María J. Rodríguez-Lagunas, María L. Garduño-Ramírez and María Rincón
Pharmaceutics 2024, 16(5), 643; https://doi.org/10.3390/pharmaceutics16050643 - 10 May 2024
Cited by 1 | Viewed by 2016
Abstract
Recently, the number of people acquiring tattoos has increased, with tattoos gaining significant popularity in people between 20 and 40 years old. Inflammation is a common reaction associated with tattooing. The purpose of this study was to evaluate a nanostructured lipid carrier loading [...] Read more.
Recently, the number of people acquiring tattoos has increased, with tattoos gaining significant popularity in people between 20 and 40 years old. Inflammation is a common reaction associated with tattooing. The purpose of this study was to evaluate a nanostructured lipid carrier loading pranoprofen (PRA-NLC) as a tattoo aftercare formulation to reduce the inflammation associated with tattooing. In this context, the in vitro drug release and the ex vivo permeation-through-human-skin tests using Franz cells were appraised. The tolerance of our formulation on the skin was evaluated by studying the skin’s biomechanical properties. In addition, an in vivo anti-inflammatory study was conducted on mice skin to evaluate the efficacy of the formulation applied topically after tattooing the animals. PRA-NLC showed a sustained release up to 72 h, and the amount of pranoprofen retained in the skin was found to be 33.48 µg/g/cm2. The formulation proved to be well tolerated; it increased stratum corneum hydration, and no signs of skin irritation were observed. Furthermore, it was demonstrated to be non-cytotoxic since the cell viability was greater than 80%. Based on these results, we concluded that PRA-NLC represents a suitable drug delivery carrier for the transdermal delivery of pranoprofen to alleviate the local skin inflammation associated with tattooing. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Preparation of PRA-NLC via a high-pressure homogenization technique.</p>
Full article ">Figure 2
<p>Ex vivo skin permeation study’s steps representation.</p>
Full article ">Figure 3
<p>Experimental back tattoo groups in a hairless mouse model: (<b>A</b>–<b>C</b>) negative control at 5, 25, and 45 min, respectively; (<b>D</b>–<b>F</b>) positive group at 5, 25, and 45 min, respectively; (<b>G</b>–<b>I</b>) group treated with PRA-NLC at 5, 25, and 45 min, respectively.</p>
Full article ">Figure 4
<p>Devices for the measure of biochemical parameters in the backs of hairless rats: (<b>A</b>) thermometer to measure T (°C); (<b>B</b>) Corneometer<sup>®</sup> probe to measure SCH (arbitrary units); (<b>C</b>) TEWL-Dermalab<sup>®</sup> probe to measure TEWL (g/h·m<sup>2</sup>).</p>
Full article ">Figure 5
<p>In vitro release profile of PRA from the nanostructured lipid carriers compared to the plain solution.</p>
Full article ">Figure 6
<p>In vitro cytotoxicity of PRA-NLC suspension and the plain solution of PRA in HaCaT cells exposed for 24 h at different concentrations.</p>
Full article ">Figure 7
<p>Skin biomechanical parameters on healthy-skin volunteers: (<b>A</b>) TEWL (g/h·m<sup>2</sup>) of PRA-NLC; (<b>B</b>) stratum corneum hydration of PRA-NLC expressed as arbitrary units (<span class="html-italic">n</span> = 10). <span class="html-italic">p</span>-values: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001. ns = non-significant.</p>
Full article ">Figure 8
<p>Macroscopic appearance of the ear’s aspect: (<b>A</b>) negative control group (control condition); (<b>B</b>) positive control group (redness and edema); (<b>C</b>) PRA-NLC treatment group.</p>
Full article ">Figure 9
<p>Skin thickness values of the mouse ears (mm). <span class="html-italic">p</span>-values: ** <span class="html-italic">p</span> &lt; 0.01. ns = non-significant.</p>
Full article ">Figure 10
<p>Representative images of histological sections obtained from xylol-induced inflammation model: (<b>A</b>) control conditions; (<b>B</b>) positive control; (<b>C</b>) PRA-NLC group. The asterisk indicates leucocyte infiltrate. e = epidermis; d = dermis; ac = auricular cartilage 100× magnification. Scale bar = 200 µm.</p>
Full article ">Figure 11
<p>Biomechanical properties evaluation from the back-tattoo-in-hairless-rat experiment: (<b>A</b>) stratum corneum hydration (SCH); (<b>B</b>) transepidermal water loss (TEWL); (<b>C</b>) skin temperature. <span class="html-italic">p</span>-values: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, ns = non-significant.</p>
Full article ">Figure 12
<p>Histological images of skin sections obtained from the back-tattoo-in-hairless-rat experiment: (<b>A</b>) negative group or control conditions; (<b>B</b>) positive group: tattooed skin and covered with ink; (<b>C</b>) PRA-NLC group, i.e., treatment with PRA-NLC after making a tattoo and covering with ink. Asterisk indicates increased epithelium. e = epidermis; d = dermis; sc = stratum corneum 100× magnification. Scale bar = 200 µm.</p>
Full article ">
25 pages, 26654 KiB  
Article
Nitrocellulose for Prolonged Permeation of Levofloxacin HCl-Salicylic Acid In Situ Gel
by Ei Mon Khaing, Kritamorn Jitrangsri, Parichart Chomto and Thawatchai Phaechamud
Polymers 2024, 16(7), 989; https://doi.org/10.3390/polym16070989 - 4 Apr 2024
Cited by 2 | Viewed by 1765
Abstract
Currently, the application of solvent exchange-induced in situ gel is underway for drug delivery to the body target site. Nitrocellulose was attempted in this research as the matrix-forming agent in solvent exchange-induced in situ gel for acne and periodontitis treatments. The gel incorporated [...] Read more.
Currently, the application of solvent exchange-induced in situ gel is underway for drug delivery to the body target site. Nitrocellulose was attempted in this research as the matrix-forming agent in solvent exchange-induced in situ gel for acne and periodontitis treatments. The gel incorporated a combination of 1% w/w levofloxacin HCl and 2% w/w salicylic acid as the active compounds. In order to facilitate formulation development, the study explored the matrix-forming behavior of different concentrations of nitrocellulose in N-methyl pyrrolidone (NMP). Consequently, their physicochemical properties and matrix-forming behavior, as well as antimicrobial and anti-inflammatory activities, were evaluated using the agar cup diffusion method and thermal inhibition of protein denaturation in the egg albumin technique, respectively. All prepared formulations presented as clear solutions with Newtonian flow. Their contact angles on agarose gel were higher than on a glass slide due to matrix formation upon exposure to the aqueous phase of agarose, with an angle of less than 60° indicating good spreadability. Nitrocellulose concentrations exceeding 20% initiated stable opaque matrix formation upon contact with phosphate buffer pH 6.8. The high hardness and remaining force of the transformed gel indicated their robustness after solvent exchange. Fluorescence tracking using sodium fluorescein and Nile red confirmed the retardation of NMP and water diffusion by the nitrocellulose matrix. From the Franz cell permeation study, these drugs could permeate through neonate porcine skin and tissue of porcine buccal from the nitrocellulose in situ forming gel. Their accumulation in these tissues might enable the inhibition of the invading bacterial pathogens. The developed in situ gels effectively inhibited Staphylococcus aureus, Staphylococcus epidermidis, Propionibacterium acnes, and Porphyromonas gingivalis. Furthermore, the formulations demonstrated an anti-inflammatory effect. The low viscosity of LvSa25Nc makes it appropriate for injectable treatments targeting periodontitis, while the higher viscosity of LvSa40Nc renders it appropriate for topical applications in acne treatment. Therefore, the nitrocellulose in situ gel loaded with combined levofloxacin HCl and salicylic acid emerges as a promising dosage form for treating acne and periodontitis. Full article
(This article belongs to the Special Issue Advanced Polymeric Materials for Pharmaceutical Applications IV)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structures of nitrocellulose (<b>A</b>), N-methyl pyrrolidone (NMP) (<b>B</b>), salicylic acid (<b>C</b>), and levofloxacin HCl (<b>D</b>).</p>
Full article ">Figure 2
<p>Viscosity (<b>A</b>) and plot of shear rate and shear stress (<b>B</b>) of levofloxacin HCl and salicylic acid-loaded nitrocellulose in situ gel formulations and control groups.</p>
Full article ">Figure 3
<p>Change in matrix formation of levofloxacin HCl and salicylic acid-loaded nitrocellulose in situ gel formulations and control groups in PBS pH 6.8.</p>
Full article ">Figure 4
<p>Mechanical property of levofloxacin HCl and salicylic acid-loaded nitrocellulose in situ gel formulations and control groups.</p>
Full article ">Figure 5
<p>Interface interaction between noncolored agarose gel (<b>left</b>) against Nile red-loaded formulations (<b>right</b>) under an inverted fluorescent microscope at magnification of 40×.</p>
Full article ">Figure 6
<p>Interface interaction between noncolored agarose gel (<b>left</b>) against sodium fluorescence-loaded formulations (<b>right</b>) under an inverted fluorescent microscope at magnification of 40×.</p>
Full article ">Figure 7
<p>Interface interaction between sodium fluorescence-loaded agarose gel (<b>left</b>) against noncolored formulations (<b>right</b>) under an inverted fluorescent microscope at magnification of 40×.</p>
Full article ">Figure 8
<p>Interface interaction between sodium fluorescence-loaded agarose gel (<b>left</b>) against Nile red-loaded formulations (<b>right</b>) under an inverted fluorescent microscope at magnification of 40×.</p>
Full article ">Figure 9
<p>Permeation of salicylic acid (<b>A</b>) and levofloxacin HCl (<b>B</b>) through neonate porcine skin into PBS pH 5.5.</p>
Full article ">Figure 10
<p>Permeation of salicylic acid (<b>A</b>) and levofloxacin HCl (<b>B</b>) through porcine buccal membrane into PBS pH 6.8.</p>
Full article ">Figure 11
<p>% Inhibition of protein denaturation of SaN, LvSa25Nc, LvSa40Nc, 0.9% NaCl, and 750 mcg/mL diclofenac sodium. The asterisk * symbol indicates a significant difference <span class="html-italic">(p</span> &lt; 0.01) between three formulations and 0.9% NaCl, and ** symbol indicates a significant difference (<span class="html-italic">p</span> &lt; 0.05) between three formulations by using one-way ANOVA followed by an LSD post hoc test.</p>
Full article ">Figure 12
<p>Photographs of the inhibition zone of levofloxacin HCl and salicylic acid-loaded nitrocellulose in situ gel formulations and control groups against <span class="html-italic">S. aureus</span> 6538 (<b>first row</b>) and <span class="html-italic">S. epidermidis</span> 5868 (<b>second row</b>).</p>
Full article ">Figure 13
<p>Photographs of the inhibition zone of levofloxacin HCl and salicylic acid-loaded nitrocellulose in situ gel formulations and control groups against <span class="html-italic">P. acnes</span> ATCC 14,916.</p>
Full article ">Figure 14
<p>Photographs of the inhibition zone of levofloxacin HCl and salicylic acid-loaded nitrocellulose in situ gel formulations and control groups against <span class="html-italic">P. gingivalis</span> ATCC 33,277.</p>
Full article ">
13 pages, 3065 KiB  
Article
Topical Nanoemulsions as Delivery Systems for Green Extracts of Pterocaulon balansae Aiming at the Treatment of Sporotrichosis
by Bruna Medeiros-Neves, Daiane Heidrich, Roselena Silvestri Schuh, Nathalya Tesch Brazil, Flávia Nathiely Silveira Fachel, Eduardo Cassel, Rubem Mário Figueiró Vargas, Maria Lúcia Scroferneker, Gilsane Lino von Poser, Letícia Scherer Koester and Helder Ferreira Teixeira
Pharmaceutics 2024, 16(4), 492; https://doi.org/10.3390/pharmaceutics16040492 - 2 Apr 2024
Viewed by 1101
Abstract
Coumarins are benzopyrones found in several plant genera, including Pterocaulon (Asteraceae). These compounds represent an important source of new treatments, especially as antimicrobial and antifungal agents. In this study, two coumarin-rich extracts from Pterocaulon balansae using green technologies were obtained through aqueous maceration [...] Read more.
Coumarins are benzopyrones found in several plant genera, including Pterocaulon (Asteraceae). These compounds represent an important source of new treatments, especially as antimicrobial and antifungal agents. In this study, two coumarin-rich extracts from Pterocaulon balansae using green technologies were obtained through aqueous maceration (AE) and supercritical fluid extraction (SFE). Such extracts were incorporated into nanoemulsions (NAE and NSFE) composed of a medium-chain triglyceride oil core stabilized by phospholipids. The nanoemulsions exhibited droplet sizes between 127 and 162 nm, pH above 5.0, and viscosity of approximately 1.0 cP, properties compatible with the topical route. The coumarins permeation/retention from formulations through ear porcine skin using Franz-type diffusion cells were evaluated. Whatever the extract, coumarins were distributed in skin layers, especially in the dermis in both intact and impaired (tape stripping) skin. In addition, a significant increase in coumarins that reached up to the receptor fluid was observed for impaired skin, with increases of approximately threefold for NAE and fourfold for NSFE. Finally, antifungal activity of nanoemulsions was evaluated according to minimum inhibitory concentrations, and the values were 250 µg/mL for all strains tested. The overall results demonstrated the feasibility of incorporating P. balansae extracts into nanoemulsions and showed a potential alternative for the treatment of sporotrichosis. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Structure, molecular weight, and LogP of the coumarins described in <span class="html-italic">P. balansae</span> extracts. (<b>1</b>) 7-(2′,3′-dihydroxy-3′-methylbutyloxy)-6-methoxycoumarin, (<b>2</b>) 5-(2′,3′-dihydroxy-3′-methylbutyloxy)-6,7-methylenedioxycoumarin, (<b>3</b>) 5,6-dimethoxy-7-(3′-methyl-2′,3′-dihydroxybutyloxy)coumarin, (<b>4</b>) 5-methoxy-6,7-methylenedioxycoumarin, (<b>5</b>) 7-(2′,3′-epoxy-3′-methyl-3′-butyloxy)-6-methoxycoumarin, (<b>6</b>) 5-(2′,3′-epoxy-3′-methylbutyloxy)-6,7-methylenedioxycoumarin, and (<b>7</b>) 5,6-dimethoxy-7-(2′,3′-epoxy-3′-methylbutyloxy)coumarin.</p>
Full article ">Figure 2
<p>Chromatographic profile of (<b>A</b>) supercritical fluid extract-loaded nanoemulsion (NSFE); (<b>B</b>) aqueous extract-loaded nanoemulsion (NAE); and (<b>C</b>) blank nanoemulsions (NB). The numbering of the chromatogram peaks corresponds to the structures and chemical names presented in <a href="#pharmaceutics-16-00492-f001" class="html-fig">Figure 1</a>.</p>
Full article ">Figure 3
<p>Representative hematoxylin/eosin-stained histological (lower images) and fluorescence (upper images) images of intact and impaired skin, as control, treated with NAE for 1 h and 8 h, and treated with NSFE for 1 h and 8 h. Notes: histological images show no skin damage after treatment with the nanoemulsions. The confocal images revealed that the fluorescence was distributed throughout the skin layers when the dye was incorporated into nanoemulsions. Images were obtained after 1 h and 8 h of permeation/retention studies using a Franz diffusion cell. Images were obtained at 100× and 400× magnifications. NBD-PE was used as fluorescent dye in confocal images. NAE: aqueous extract-loaded nanoemulsion; NSFE: supercritical fluid extract-loaded nanoemulsion.</p>
Full article ">Figure 4
<p>Fluorescent intensity levels detected for impaired or intact skin relative to the percentage of fluorescence emitted by the control tissue. Statistically significant differences were determined through ANOVA with Tukey’s post hoc (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.005, *** <span class="html-italic">p</span> &lt; 0.0005). Differences between intact and impaired tissues are represented by (#), while differences between 1 h and 8 h of incubation with the same nanoemulsion are represented by (*).</p>
Full article ">
16 pages, 1595 KiB  
Article
Kombucha as a Potential Active Ingredient in Cosmetics—An Ex Vivo Skin Permeation Study
by Karolina Jakubczyk, Anna Nowak, Anna Muzykiewicz-Szymańska, Łukasz Kucharski, Kinga Szymczykowska and Katarzyna Janda-Milczarek
Molecules 2024, 29(5), 1018; https://doi.org/10.3390/molecules29051018 - 26 Feb 2024
Cited by 2 | Viewed by 2664
Abstract
Kombucha is a non-alcoholic beverage, that is increasingly used in the cosmetic industry. The available literature reports the positive effects of kombucha on the skin, in particular its antioxidant action. However, there is a lack of information on skin permeation and the accumulation [...] Read more.
Kombucha is a non-alcoholic beverage, that is increasingly used in the cosmetic industry. The available literature reports the positive effects of kombucha on the skin, in particular its antioxidant action. However, there is a lack of information on skin permeation and the accumulation of active ingredients showing such effects. Skin aging is largely dependent on oxidative stress, therefore in our study we assessed the ex vivo permeation of two types of kombucha (green and black tea) through porcine skin. The antioxidant activity (DPPH, ABTS, FRAP methods) and total polyphenol content of these extracts were determined before and after permeation testing. Moreover, the content of selected phenolic acids as well as caffeine was assessed. Skin permeation was determined using a Franz diffusion cell. The antioxidant activity of both Kombuchas was found to be high. In addition, gallic acid, chlorogenic acid, protocatechuic acid, coumaric acid, m-hydroxybenzoic acid, and caffeine were identified. A 24-h ex vivo study showed the permeation of some phenolic acids and caffeine and their accumulation in the skin. Our results confirm the importance of studying the skin permeation of what are still little known ingredients in cosmetic preparations. Evaluation of the accumulation of these ingredients can guarantee the efficacy of such preparations. Full article
(This article belongs to the Special Issue Natural Products and Biomolecules for Cosmetics Applications)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chromatogram of phenolic acids and caffeine identified in green (<b>a</b>) and black (<b>b</b>) tea kombucha. A—gallic acid; B—protocatechuic acid; C—chlorogenic acid; D—caffeic acid; E—caffeine, F—m-hydroxybenzoic and G—coumaric acid. Kombucha samples were diluted twice before HPLC analysis.</p>
Full article ">Figure 2
<p>Chromatograms of compounds identified in skin extract after 24-h permeation: (<b>a</b>) skin extract after permeation of green tea kombucha; (<b>b</b>) skin extract after permeation of black tea kombucha; A—gallic acid; B—protocatechuic acid; C—chlorogenic acid; D—caffeic acid; E—caffeine, F—m-hydroxybenzoic acid, and G—coumaric acid. Kombucha samples were diluted twice before HPLC analysis.</p>
Full article ">Figure 3
<p>Chromatograms of compounds identified in acceptor fluid after 24-h permeation: (<b>a</b>) acceptor fluid after 24-h permeation of green tea kombucha (<b>b</b>) acceptor fluid after 24-h permeation of black tea kombucha; A—gallic acid; B—protocatechuic acid; C—chlorogenic acid; D—caffeic acid; E—caffeine, F—m-hydroxybenzoic acid, and G—coumaric acid. Kombucha samples were diluted twice before HPLC analysis.</p>
Full article ">Figure 4
<p>Time course of the cumulative mass of caffeine expressed in µg CAF·cm<sup>−2</sup> during the 24-h permeation of kombuchas. CAF–caffeine, (n = 3).</p>
Full article ">
17 pages, 6150 KiB  
Article
Foams Set a New Pace for the Release of Diclofenac Sodium
by Fanni Falusi, Szilvia Berkó, Mária Budai-Szűcs, Zoltán Veréb and Anita Kovács
Pharmaceutics 2024, 16(2), 287; https://doi.org/10.3390/pharmaceutics16020287 - 18 Feb 2024
Viewed by 1825
Abstract
Medicated foams have emerged as promising alternatives to traditional carrier systems in pharmaceutical research. Their rapid and convenient application allows for effective treatment of extensive or hirsute areas, as well as sensitive or inflamed skin surfaces. Foams possess excellent spreading capabilities on the [...] Read more.
Medicated foams have emerged as promising alternatives to traditional carrier systems in pharmaceutical research. Their rapid and convenient application allows for effective treatment of extensive or hirsute areas, as well as sensitive or inflamed skin surfaces. Foams possess excellent spreading capabilities on the skin, ensuring immediate drug absorption without the need for intense rubbing. Our research focuses on the comparison of physicochemical and biopharmaceutical properties of three drug delivery systems: foam, the foam bulk liquid, and a conventional hydrogel. During the development of the composition, widely used diclofenac sodium was employed. The safety of the formulae was confirmed through an in vitro cytotoxicity assay. Subsequently, the closed Franz diffusion cell was used to determine drug release and permeation in vitro. Ex vivo Raman spectroscopy was employed to investigate the presence of diclofenac sodium in various skin layers. The obtained results of the foam were compared to the bulk liquid and to a conventional hydrogel. In terms of drug release, the foam showed a rapid release, with 80% of diclofenac released within 30 min. In summary, the investigated foam holds promising potential as an alternative to traditional dermal carrier systems, offering faster drug release and permeation. Full article
(This article belongs to the Special Issue Topical Drug Carriers: Recent Advances and Future Challenges)
Show Figures

Figure 1

Figure 1
<p>Effect of components on the viability of AD-MSCs.</p>
Full article ">Figure 2
<p>Microscopic images of the structure of foams produced by the pump and mechanical stirrer: (<b>a</b>) polymer- and DS-free foams; (<b>b</b>) xanthan-gum-containing, DS-free foam; (<b>c</b>) xanthan-gum- and DS-containing foam. The images were captured at 50× magnification.</p>
Full article ">Figure 3
<p>The untreated skin was used as a negative control. The stratum corneum with the upper skin layers (<b>A</b>) and the lower skin layers (<b>B</b>). The examination was conducted at a magnification of 200×.</p>
Full article ">Figure 4
<p>Images of the positive control: Relative Intensity Values at 10 and 30 min. The examination was conducted at a magnification of 200×.</p>
Full article ">Figure 5
<p>Images of the skin treated with the foam formulation: Relative Intensity Values at 10 and 30 min. The examination was conducted at a magnification of 200×.</p>
Full article ">Figure 6
<p>The release profile of DS in different dosage forms (*** <span class="html-italic">p</span> ≤ 0.001 vs. foam, * <span class="html-italic">p</span> ≤ 0.05 vs. foam).</p>
Full article ">Figure 7
<p>Kinetics of ex vivo drug permeation of bulk liquid.</p>
Full article ">Figure 8
<p>Kinetics of ex vivo drug permeation of foam.</p>
Full article ">Figure 9
<p>Kinetics of ex vivo drug permeation of hydrogel.</p>
Full article ">
32 pages, 3676 KiB  
Article
Fabricating Polymer/Surfactant/Cyclodextrin Hybrid Particles for Possible Nose-to-Brain Delivery of Ropinirole Hydrochloride: In Vitro and Ex Vivo Evaluation
by Elmina-Marina Saitani, Natassa Pippa, Diego Romano Perinelli, Aleksander Forys, Paraskevi Papakyriakopoulou, Nefeli Lagopati, Giulia Bonacucina, Barbara Trzebicka, Maria Gazouli, Stergios Pispas and Georgia Valsami
Int. J. Mol. Sci. 2024, 25(2), 1162; https://doi.org/10.3390/ijms25021162 - 18 Jan 2024
Cited by 6 | Viewed by 2670
Abstract
Ropinirole is a non-ergolinic dopamine agonist used to manage Parkinson’s disease and it is characterized by poor oral bioavailability. This study aimed to design and develop advanced drug delivery systems composed of poloxamer 407, a non-ionic surfactant (Tween 80), and cyclodextrins (methyl-β-CD or [...] Read more.
Ropinirole is a non-ergolinic dopamine agonist used to manage Parkinson’s disease and it is characterized by poor oral bioavailability. This study aimed to design and develop advanced drug delivery systems composed of poloxamer 407, a non-ionic surfactant (Tween 80), and cyclodextrins (methyl-β-CD or hydroxy-propyl-β-CD) for possible brain targeting of ropinirole after nasal administration for the treatment of Parkinson’s disease. The hybrid systems were formed by the thin-film hydration method, followed by an extensive physicochemical and morphological characterization. The in vitro cytotoxicity of the systems on HEK293 cell lines was also tested. In vitro release and ex vivo mucosal permeation of ropinirole were assessed using Franz cells at 34 °C and with phosphate buffer solution at pH 5.6 in the donor compartment, simulating the conditions of the nasal cavity. The results indicated that the diffusion-controlled drug release exhibited a progressive increase throughout the experiment, while a proof-of-concept experiment on ex vivo permeation through rabbit nasal mucosa revealed a better performance of the prepared hybrid systems in comparison to ropinirole solution. The encouraging results in drug release and mucosal permeation indicate that these hybrid systems can serve as attractive platforms for effective and targeted nose-to-brain delivery of ropinirole with a possible application in Parkinson’s disease. Further ex vivo and in vivo studies to support the results of the present work are ongoing. Full article
(This article belongs to the Special Issue Cyclodextrins: Properties and Applications)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structures of (<b>A</b>) poloxamer 407, (<b>Β</b>) Tween 80, (<b>C</b>) methyl-β-cyclodextrin, (<b>D</b>) hydroxypropyl-β-cyclodextrin, and (<b>E</b>) ropinirole hydrochloride.</p>
Full article ">Figure 2
<p>DSC thermograms. The heating curves of (<b>a</b>) P407, (<b>b</b>) P407/Tw80, (<b>c</b>) P407/MβCD, (<b>d</b>) P407/HPβCD, (<b>e</b>) P407/Tw80/MβCD, (<b>f</b>) P407/Tw80/HPβCD. The limits for the calculation of thermotropic parameters are from 10 °C to 300 °C.</p>
Full article ">Figure 3
<p>(<b>A</b>) mDSC traces and (<b>B</b>) sound speed vs. temperature profiles from HR-US for P407, P407/Tw80, P407/Tw80/MβCD, and P407/Tw80/HPβCD formulations.</p>
Full article ">Figure 4
<p>Cryo-TEM micrographs of hybrid P407/Tw80/MβCD (<b>A</b>,<b>B</b>) and P407/Tw80/HPβCD (<b>C</b>,<b>D</b>) systems.</p>
Full article ">Figure 5
<p>MTΤ cell viability assay after 24 h treatment of HEK-293 of hybrid colloidal systems: pure P407, P407/Tw80, P407/Tw80/MβCD, and P407/Tw80/HPβCD systems. Cell viability is expressed as % cell viability ± SD between two experiments.</p>
Full article ">Figure 6
<p>DSC thermograms. Heating curves of (<b>A</b>) (<b>a</b>) RH and (P407/Tw80/MβCD)/RH at different weight ratios: (<b>b</b>) 10:10, (<b>c</b>) 10:5, (<b>d</b>) 10:1, (<b>e</b>) 10:0.5, (<b>f</b>) 10:0.1. Heating curves of (<b>B</b>) (<b>a</b>) RH and (P407/Tw80/HPβCD)/RH at different weight ratios: (<b>b</b>) 10:10, (<b>c</b>) 10:5, (<b>d</b>) 10:1, (<b>e</b>) 10:0.5, (<b>f</b>) 10:0.1. The limits for the calculation of thermotropic parameters are from 10 °C to 300 °C.</p>
Full article ">Figure 7
<p>Illustration of the RH systems based on the results obtained from the applied techniques.</p>
Full article ">Figure 8
<p>Permeation profiles of RH P407 ternary systems through regenerated cellulose membranes for colloidal dispersions at weight ratios of 10:1 and 10:5 in comparison to RH solution (0.5 mg/mL). Results are expressed as (<b>A</b>) quantity permeated per unit area (mean ± SD, <span class="html-italic">n</span> = 3) and (<b>B</b>) % loading dose permeated for the tested formulation (mean ± SD, <span class="html-italic">n</span> = 3).</p>
Full article ">Figure 9
<p>Permeation profiles for colloidal dispersions of RH P407 ternary systems through rabbit nasal mucosa for formulations at weight ratios of 10:1 and 10:5 in comparison to RH solution (0.5 mg/mL). Results are expressed as (<b>A</b>) quantity permeated per unit area (mean ± SEM, <span class="html-italic">n</span> = 4) and (<b>B</b>) % loading dose permeated for the tested formulation (mean ± SEM, <span class="html-italic">n</span> = 4).</p>
Full article ">
13 pages, 3617 KiB  
Article
Study on Influencing Factors of Nicotinamide Transdermal Absorption In Vitro and the Establishment of an Evaluation Method
by Wanping Zhang, Xuefang Shi and Shilian Zheng
Processes 2024, 12(1), 202; https://doi.org/10.3390/pr12010202 - 17 Jan 2024
Viewed by 1432
Abstract
The goal of this research was to study the factors influencing the in vitro transdermal penetration of nicotinamide and to establish an evaluation method for the in vitro transdermal absorption of nicotinamide. The permeability of nicotinamide was investigated with Franz diffusion cell in [...] Read more.
The goal of this research was to study the factors influencing the in vitro transdermal penetration of nicotinamide and to establish an evaluation method for the in vitro transdermal absorption of nicotinamide. The permeability of nicotinamide was investigated with Franz diffusion cell in vitro transcutaneous assays, and the effect of the receiving solution composition, receiving solution pH, skin type, diffusion cell temperature, active ingredient concentration, supply quantity, and product dosage form on its permeation was investigated separately by high-performance liquid chromatography. The best assay for the transdermal absorption of nicotinamide was established—there was a better transdermal absorption performance, more stable system, better applicability, and better reproducibility when the receiving solution was PBS (phosphate-buffered saline) solution, the pH was 7.4, the membrane was pig ear skin, the temperature was 37 °C, the concentration of nicotinamide was 3%, and the dose of the test substance was 2 g. In the three cosmetic dosage forms of toning lotion, milk lotion, and gel, the permeability of milk lotion was the highest, followed by toning lotion and gel. Full article
Show Figures

Figure 1

Figure 1
<p>Cumulative permeability of nicotinamide under different receiving fluid conditions (n = 3).</p>
Full article ">Figure 2
<p>Cumulative permeability of nicotinamide at different pH values (n = 3).</p>
Full article ">Figure 3
<p>Cumulative permeability of nicotinamide under different skin conditions (n = 3).</p>
Full article ">Figure 4
<p>Cumulative permeability of nicotinamide at different temperatures (n = 3).</p>
Full article ">Figure 5
<p>Cumulative permeability of nicotinamide at different concentrations (n = 3).</p>
Full article ">Figure 6
<p>Cumulative permeability of nicotinamide under different doses conditions (n = 3). (<b>a</b>) Doses: 31.4 mg; (<b>b</b>) Doses: 2 g.</p>
Full article ">Figure 7
<p>Cumulative permeability of nicotinamide under different polyols (n = 3).</p>
Full article ">Figure 8
<p>Cumulative permeability of nicotinamide under different rheological regulators (n = 3).</p>
Full article ">Figure 9
<p>Cumulative permeability of nicotinamide under different emulsifiers (n = 3).</p>
Full article ">Figure 10
<p>Cumulative permeability of nicotinamide under different oil conditions (n = 3).</p>
Full article ">
21 pages, 3066 KiB  
Article
Ethosomes for Curcumin and Piperine Cutaneous Delivery to Prevent Environmental-Stressor-Induced Skin Damage
by Francesca Ferrara, Agnese Bondi, Walter Pula, Catia Contado, Anna Baldisserotto, Stefano Manfredini, Paola Boldrini, Maddalena Sguizzato, Leda Montesi, Mascia Benedusi, Giuseppe Valacchi and Elisabetta Esposito
Antioxidants 2024, 13(1), 91; https://doi.org/10.3390/antiox13010091 - 11 Jan 2024
Cited by 7 | Viewed by 2433
Abstract
Diesel particulate matter is one of the most dangerous environmental stressors affecting human health. Many plant-derived compounds with antioxidant and anti-inflammatory properties have been proposed to protect the skin from pollution damage. Curcumin (CUR) has a plethora of pharmacological activities, including anticancer, antimicrobial, [...] Read more.
Diesel particulate matter is one of the most dangerous environmental stressors affecting human health. Many plant-derived compounds with antioxidant and anti-inflammatory properties have been proposed to protect the skin from pollution damage. Curcumin (CUR) has a plethora of pharmacological activities, including anticancer, antimicrobial, anti-inflammatory and antioxidant. However, it has low bioavailability due to its difficult absorption and rapid metabolism and elimination. CUR encapsulation in nanotechnological systems and its combination with biopotentiators such as piperine (PIP) can improve its pharmacokinetics, stability and activity. In this study, ethosomes (ETs) were investigated for CUR and PIP delivery to protect the skin from damage induced by diesel particulate matter. ETs were produced by different strategies and characterized for their size distribution by photon correlation spectroscopy, for their morphology by transmission electron microscopy, and for their drug encapsulation efficiency by high-performance liquid chromatography. Franz cells enabled us to evaluate in vitro the drug diffusion from ETs. The results highlighted that ETs can promote the skin permeation of curcumin. The studies carried out on their antioxidant activity demonstrated an increase in the antioxidant power of CUR using a combination of CUR and PIP separately loaded in ETs, suggesting their possible application for the prevention of skin damage due to exogenous stressors. Ex vivo studies on human skin explants have shown the suitability of drug-loaded ETs to prevent the structural damage to the skin induced by diesel engine exhaust exposure. Full article
(This article belongs to the Collection Advances in Antioxidant Ingredients from Natural Products)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Transmission electron micrographs of ETs (<b>a</b>), ET–CUR (<b>b</b>) and ET–PIP (<b>c</b>). The bar corresponds to 150, 100 and 200 nm in panels (<b>a</b>), (<b>b</b>), (<b>c</b>), respectively.</p>
Full article ">Figure 2
<p>CUR and PIP release kinetics from ET–CUR (red circles), SOL–CUR (blue squares), ET–PIP (green circles) and SOL–PIP (black squares), as determined by Franz cells associated with the PTFE membrane. Data are the mean of 6 independent experiments ± s.d.</p>
Full article ">Figure 3
<p>CUR (<b>a</b>,<b>b</b>) and PIP (<b>c</b>,<b>d</b>) permeability kinetics from ET–CUR (red circles), SOL–CUR (blue squares), ET–PIP (green circles) and SOL–PIP (black squares), as determined by Franz cells associated with the Strat-M membrane. (<b>a</b>,<b>c</b>) Panels show the linear part of the kinetic profiles; (<b>b</b>,<b>d</b>) Panels show diffusion profile over 0–24 h. Data are the mean of 6 independent experiments ± s.d.</p>
Full article ">Figure 4
<p>Immunofluorescence staining for 4HNE (<b>a</b>) filaggrin (<b>b</b>) and type I collagen (<b>c</b>) in human skin biopsies treated with the indicated formulations and exposed to DEE. Red or green staining represents the selected proteins, and the blue staining (DAPI) represents nuclei. Images were taken at 40× magnification. The fluorescent signal of the different markers was quantified using ImageJ software 1.53a (Java 1.8.0_172) and is expressed in the graphs. Data are the results of the averages of at least three different experiments, with *<sup>,#,<span>$</span></sup> <span class="html-italic">p</span> &lt; 0.05; <sup>##,</sup> <span class="html-italic">p</span> &lt; 0.005; <sup>###,</sup> <span class="html-italic">p</span> &lt; 0.001; and <sup>****,####,</sup> <span class="html-italic">p</span> &lt; 0.0001, by 2-way ANOVA followed by Tukey’s post hoc comparison test [<a href="#B57-antioxidants-13-00091" class="html-bibr">57</a>]. DEE, SOL–CUR + DEE, SOL–PIP + DEE, SOL–PIP + SOL–CUR + DEE, ET–CUR, ET–PIP, ET–PIP + ET–CUR + DEE vs. Ctrl (*); CTRL, SOL–CUR + DEE, SOL–PIP + DEE, SOL–PIP + SOL–CUR + DEE, ET–CUR, ET–PIP, ET–PIP + ET–CUR + DEE vs. DEE (<sup>#</sup>); SOL–PIP + SOL–CUR + DEE vs. SOL–CUR + DEE (<sup><span>$</span></sup>).</p>
Full article ">
Back to TopTop